Medical Mycology

Papers
(The H4-Index of Medical Mycology is 17. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)
ArticleCitations
P041 Preliminary evaluation of gradient concentration strips for detection of terbinafine resistance in Trichophyton spp.33
Correction to: Oral Presentations26
Effective detection of azole resistance in Aspergillus fumigatus sensu stricto using a gradient diffusion plastic strip: A comparison of filtered-adjusted vs. unfiltered-unadjusted inocula26
Novel in vivo observations of luliconazole 5% nail solution for onychomycosis: An ultrastructural study25
Histoplasmosis screening using urinary antigen detection in people living with HIV in Southern Brazil25
S3.4a The repurposing approach identifies pitavastatin (calcium) making fluconazole fungicidal by inhibiting ergosterol synthesis24
Correction to: The high diversity of Scedosporium and Lomentospora species and their prevalence in human-disturbed areas in Taiwan23
P025 A study on candiduria in neonates and infants from a tertiary care center, North India.23
S1.4d Cryptococcus qPCR assays: the future for routine mycology labs and clinical trials dealing with cryptococcosis22
COP27 Climate Change Conference: Urgent action needed for Africa and the world21
P133 Post-COVID-19 recurrent fungal urinary tract infections: A case series19
P482 Burden of serious fungal infections in India18
S2.2d Evaluation of new tools for the diagnosis of histoplasmosis18
S4.2d Efficacy of LD Bio Aspergillus ICT lateral flow assay for serodiagnosis of chronic pulmonary aspergillosis18
P011 Antifungal lock therapy18
P337 Species distribution and biofilm profile of Candida isolated from clinical specimens at a tertiary care hospital in India17
S6.5d Molecular identification of mycetoma causative agents from patients in ahospital setting in Senegal17
S7.2d Divergent EGFR/MAPK-mediated immune responses to clinical Candida pathogens in vulvovaginal candidiasis17
0.1108078956604